About this Research Topic
Frontiers in Stroke is delighted to present the ‘Reviews in’ series of article collections.
Reviews in Acute Stroke and Interventional Therapies will publish high-quality scholarly review papers on key topics in the field of acute stroke therapies. Over the past two decades, the care for patients with acute stroke has been greatly improved thanks to the advancement in drugs, therapeutic devices, and imaging modalities. This review collection aims to highlight recent advances in the field and identify the unmet clinical need, whilst emphasizing important directions and new possibilities for future inquiries. We anticipate this collection of reviews will spark discussions and new ideas among clinicians, scientists, and engineers and promote interdisciplinary collaborations to translate novel interventional therapies for acute stroke from the lab to the patients’ bedside.
The Reviews in Acute Stroke and Interventional Therapies collection welcomes full-length, mini or systematic reviews on clinical and translational studies on, but not limited to, the following topics:
- Safety, efficacy, and the latest advancement of thrombectomy devices
- Safety, efficacy, and the latest advancement of thrombolytic agents
- Thrombolysis and thrombectomy for medium and distal vessel occlusions
- Histological, physical, and imaging characteristics of clots causing stroke and their implications to pathophysiology, stroke etiology, treatment methods, and patient outcome
- In vitro and in vivo animal models for acute stroke
- Neuroprotective agents and devices
- Stroke telemedicine
Dr. Yang Liu is a co-author on patents for: devices for treating intracranial hematoma (PCT/US2021/029276), a hydrodynamic vortex aspiration catheter (US 10,960,178) licensed to Endovascular Engineering Inc., and a technique to restore artery patency and a catheter temperature control system in atherectomy (US 10,945,757) licensed to Guangzhou Boxin Medical Technology Co. Ltd.
Dr. Luis Savastano is the founder and Chief Scientific Officer of Endovascular Engineering, Inc, the Chief Medical Officer of VerAvanti, Inc, and the founder of Endovascular Horizons Inc and Neurovascular Technologies LLC. He is co-inventor of patents for mechanical thrombectomy (US20210045770A1 and WO 2019/199931A1) and treatment of intracranial hematoma (WO2021222157A1). He is a consultant for Medtronic, Stryker, and Microvention.
The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Reviews in Acute Stroke and Interventional Therapies will publish high-quality scholarly review papers on key topics in the field of acute stroke therapies. Over the past two decades, the care for patients with acute stroke has been greatly improved thanks to the advancement in drugs, therapeutic devices, and imaging modalities. This review collection aims to highlight recent advances in the field and identify the unmet clinical need, whilst emphasizing important directions and new possibilities for future inquiries. We anticipate this collection of reviews will spark discussions and new ideas among clinicians, scientists, and engineers and promote interdisciplinary collaborations to translate novel interventional therapies for acute stroke from the lab to the patients’ bedside.
The Reviews in Acute Stroke and Interventional Therapies collection welcomes full-length, mini or systematic reviews on clinical and translational studies on, but not limited to, the following topics:
- Safety, efficacy, and the latest advancement of thrombectomy devices
- Safety, efficacy, and the latest advancement of thrombolytic agents
- Thrombolysis and thrombectomy for medium and distal vessel occlusions
- Histological, physical, and imaging characteristics of clots causing stroke and their implications to pathophysiology, stroke etiology, treatment methods, and patient outcome
- In vitro and in vivo animal models for acute stroke
- Neuroprotective agents and devices
- Stroke telemedicine
Dr. Yang Liu is a co-author on patents for: devices for treating intracranial hematoma (PCT/US2021/029276), a hydrodynamic vortex aspiration catheter (US 10,960,178) licensed to Endovascular Engineering Inc., and a technique to restore artery patency and a catheter temperature control system in atherectomy (US 10,945,757) licensed to Guangzhou Boxin Medical Technology Co. Ltd.
Dr. Luis Savastano is the founder and Chief Scientific Officer of Endovascular Engineering, Inc, the Chief Medical Officer of VerAvanti, Inc, and the founder of Endovascular Horizons Inc and Neurovascular Technologies LLC. He is co-inventor of patents for mechanical thrombectomy (US20210045770A1 and WO 2019/199931A1) and treatment of intracranial hematoma (WO2021222157A1). He is a consultant for Medtronic, Stryker, and Microvention.
The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Keywords: #CollectionSeries, Reviews in Acute Stroke and Interventional Therapies
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
